SPI
17.391,52
PKT
-153,53
PKT
-0,88
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.08.12 | Givaudan hold | Vontobel Research | |
| 30.08.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 30.08.12 | Zurich Insurance sell | Landesbank Baden-Württemberg (LBBW) | |
| 30.08.12 | Vetropack A hold | Vontobel Research | |
| 30.08.12 | TX Group buy | Sarasin Research | |
| 30.08.12 | Emmi neutral | Sarasin Research | |
| 30.08.12 | Baloise neutral | Sarasin Research | |
| 30.08.12 | Baloise hold | Vontobel Research | |
| 30.08.12 | Implenia buy | Vontobel Research | |
| 30.08.12 | Givaudan hold | Vontobel Research | |
| 30.08.12 | SHL Telemedicine hold | Vontobel Research | |
| 30.08.12 | Emmi hold | Vontobel Research | |
| 30.08.12 | Novartis reduce | Vontobel Research | |
| 30.08.12 | TX Group hold | Vontobel Research | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 29.08.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 29.08.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 29.08.12 | Orascom Development neutral | Sarasin Research | |
| 29.08.12 | Vetropack A hold | Vontobel Research | |
| 28.08.12 | Roche buy | Deutsche Bank AG | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | METALL ZUG hold | Vontobel Research | |
| 28.08.12 | VP Bank neutral | Sarasin Research | |
| 28.08.12 | Zug Estates B hold | Vontobel Research | |
| 28.08.12 | Clariant buy | Vontobel Research | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 27.08.12 | Roche buy | Sarasin Research | |
| 27.08.12 | Clariant buy | Sarasin Research | |
| 27.08.12 | Zug Estates B hold | Vontobel Research | |
| 27.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Huber + Suhner hold | Vontobel Research | |
| 27.08.12 | Autoneum hold | Vontobel Research | |
| 27.08.12 | METALL ZUG hold | Vontobel Research | |
| 27.08.12 | Swatch (I) buy | Sarasin Research | |
| 24.08.12 | Clariant hold | Deutsche Bank AG | |
| 24.08.12 | Roche overweight | J.P. Morgan Cazenove | |
| 24.08.12 | Givaudan sell | Deutsche Bank AG | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 24.08.12 | Peach Property Group buy | SRC Research GmbH |